210 related articles for article (PubMed ID: 21730972)
1. RNA interference improves myopathic phenotypes in mice over-expressing FSHD region gene 1 (FRG1).
Wallace LM; Garwick-Coppens SE; Tupler R; Harper SQ
Mol Ther; 2011 Nov; 19(11):2048-54. PubMed ID: 21730972
[TBL] [Abstract][Full Text] [Related]
2. AAV6-mediated systemic shRNA delivery reverses disease in a mouse model of facioscapulohumeral muscular dystrophy.
Bortolanza S; Nonis A; Sanvito F; Maciotta S; Sitia G; Wei J; Torrente Y; Di Serio C; Chamberlain JR; Gabellini D
Mol Ther; 2011 Nov; 19(11):2055-64. PubMed ID: 21829175
[TBL] [Abstract][Full Text] [Related]
3. FHL1 reduces dystrophy in transgenic mice overexpressing FSHD muscular dystrophy region gene 1 (FRG1).
Feeney SJ; McGrath MJ; Sriratana A; Gehrig SM; Lynch GS; D'Arcy CE; Price JT; McLean CA; Tupler R; Mitchell CA
PLoS One; 2015; 10(2):e0117665. PubMed ID: 25695429
[TBL] [Abstract][Full Text] [Related]
4. Rbfox1 downregulation and altered calpain 3 splicing by FRG1 in a mouse model of Facioscapulohumeral muscular dystrophy (FSHD).
Pistoni M; Shiue L; Cline MS; Bortolanza S; Neguembor MV; Xynos A; Ares M; Gabellini D
PLoS Genet; 2013; 9(1):e1003186. PubMed ID: 23300487
[TBL] [Abstract][Full Text] [Related]
5. RNA interference inhibits DUX4-induced muscle toxicity in vivo: implications for a targeted FSHD therapy.
Wallace LM; Liu J; Domire JS; Garwick-Coppens SE; Guckes SM; Mendell JR; Flanigan KM; Harper SQ
Mol Ther; 2012 Jul; 20(7):1417-23. PubMed ID: 22508491
[TBL] [Abstract][Full Text] [Related]
6. Structural and functional alterations of muscle fibres in the novel mouse model of facioscapulohumeral muscular dystrophy.
D'Antona G; Brocca L; Pansarasa O; Rinaldi C; Tupler R; Bottinelli R
J Physiol; 2007 Nov; 584(Pt 3):997-1009. PubMed ID: 17855756
[TBL] [Abstract][Full Text] [Related]
7. Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation.
Bodega B; Ramirez GD; Grasser F; Cheli S; Brunelli S; Mora M; Meneveri R; Marozzi A; Mueller S; Battaglioli E; Ginelli E
BMC Biol; 2009 Jul; 7():41. PubMed ID: 19607661
[TBL] [Abstract][Full Text] [Related]
8. Facioscapulohumeral muscular dystrophy (FSHD) region gene 1 (FRG1) is a dynamic nuclear and sarcomeric protein.
Hanel ML; Sun CY; Jones TI; Long SW; Zanotti S; Milner D; Jones PL
Differentiation; 2011 Feb; 81(2):107-18. PubMed ID: 20970242
[TBL] [Abstract][Full Text] [Related]
9. FSHD muscular dystrophy region gene 1 binds Suv4-20h1 histone methyltransferase and impairs myogenesis.
Neguembor MV; Xynos A; Onorati MC; Caccia R; Bortolanza S; Godio C; Pistoni M; Corona DF; Schotta G; Gabellini D
J Mol Cell Biol; 2013 Oct; 5(5):294-307. PubMed ID: 23720823
[TBL] [Abstract][Full Text] [Related]
10. Identification of the first gene (FRG1) from the FSHD region on human chromosome 4q35.
van Deutekom JC; Lemmers RJ; Grewal PK; van Geel M; Romberg S; Dauwerse HG; Wright TJ; Padberg GW; Hofker MH; Hewitt JE; Frants RR
Hum Mol Genet; 1996 May; 5(5):581-90. PubMed ID: 8733123
[TBL] [Abstract][Full Text] [Related]
11. Altered Tnnt3 characterizes selective weakness of fast fibers in mice overexpressing FSHD region gene 1 (FRG1).
Sancisi V; Germinario E; Esposito A; Morini E; Peron S; Moggio M; Tomelleri G; Danieli-Betto D; Tupler R
Am J Physiol Regul Integr Comp Physiol; 2014 Jan; 306(2):R124-37. PubMed ID: 24305066
[TBL] [Abstract][Full Text] [Related]
12. AAV-based gene therapies for the muscular dystrophies.
Crudele JM; Chamberlain JS
Hum Mol Genet; 2019 Oct; 28(R1):R102-R107. PubMed ID: 31238336
[TBL] [Abstract][Full Text] [Related]
13. Muscular dystrophy candidate gene FRG1 is critical for muscle development.
Hanel ML; Wuebbles RD; Jones PL
Dev Dyn; 2009 Jun; 238(6):1502-12. PubMed ID: 19097195
[TBL] [Abstract][Full Text] [Related]
14. The mouse homolog of FRG1, a candidate gene for FSHD, maps proximal to the myodystrophy mutation on chromosome 8.
Grewal PK; van Deutekom JC; Mills KA; Lemmers RJ; Mathews KD; Frants RR; Hewitt JE
Mamm Genome; 1997 Jun; 8(6):394-8. PubMed ID: 9166581
[TBL] [Abstract][Full Text] [Related]
15. Facioscapulohumeral muscular dystrophy region gene-1 (FRG-1) is an actin-bundling protein associated with muscle-attachment sites.
Liu Q; Jones TI; Tang VW; Brieher WM; Jones PL
J Cell Sci; 2010 Apr; 123(Pt 7):1116-23. PubMed ID: 20215405
[TBL] [Abstract][Full Text] [Related]
16. FSHD region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy.
Wuebbles RD; Hanel ML; Jones PL
Dis Model Mech; 2009; 2(5-6):267-74. PubMed ID: 19383939
[TBL] [Abstract][Full Text] [Related]
17. Facioscapulohumeral muscular dystrophy region gene 1 is a dynamic RNA-associated and actin-bundling protein.
Sun CY; van Koningsbruggen S; Long SW; Straasheijm K; Klooster R; Jones TI; Bellini M; Levesque L; Brieher WM; van der Maarel SM; Jones PL
J Mol Biol; 2011 Aug; 411(2):397-416. PubMed ID: 21699900
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated viral-mediated LARGE gene therapy rescues the muscular dystrophic phenotype in mouse models of dystroglycanopathy.
Yu M; He Y; Wang K; Zhang P; Zhang S; Hu H
Hum Gene Ther; 2013 Mar; 24(3):317-30. PubMed ID: 23379513
[TBL] [Abstract][Full Text] [Related]
19. Rescue of skeletal muscles of gamma-sarcoglycan-deficient mice with adeno-associated virus-mediated gene transfer.
Cordier L; Hack AA; Scott MO; Barton-Davis ER; Gao G; Wilson JM; McNally EM; Sweeney HL
Mol Ther; 2000 Feb; 1(2):119-29. PubMed ID: 10933922
[TBL] [Abstract][Full Text] [Related]
20. Decreased proliferation kinetics of mouse myoblasts overexpressing FRG1.
Chen SC; Frett E; Marx J; Bosnakovski D; Reed X; Kyba M; Kennedy BK
PLoS One; 2011; 6(5):e19780. PubMed ID: 21603621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
